Alcami

Alcami is a well-established, privately-held CDMO headquartered in Wilmington, North Carolina, serving the pharmaceutical and biotechnology sectors. The company offers a comprehensive suite of services encompassing sterile fill-finish and oral solid dose manufacturing, extensive analytical and microbiological testing, and specialized cGMP storage with ancillary support services. Backed by private equity firms GHO Capital, The Vistria Group, and Ampersand Capital Partners, Alcami positions itself as a partner for clients with unique product needs, supporting a broad range of molecules from small molecules to biologics and cell and gene therapies.

Integrated CDMO services platform encompassing sterile fill-finish and oral solid dose drug product manufacturing, comprehensive analytical/microbiological laboratory services, and cGMP pharmaceutical storage with integrated support services (calibration, validation, monitoring).

Operates in a highly competitive and fragmented global CDMO market. Competes with large, full-service players like Lonza and Catalent, as well as numerous niche specialists in fill-finish, analytical testing, or storage. Differentiation is achieved through integrated service offerings, deep expertise in complex modalities, and a focus on client-specific solutions.